CLINICAL_TRIALS ClinicalTrials.gov record update

A Study on PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin) in Iranian Thalassemic Patients With Chronic Hepatitis C Infection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00707850
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:02.646205+00:00
Published At: 2010-08-31T00:00:00+00:00
Record Updated At: 2010-08-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis C", "Thalassemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2010-08-31"
protocolSection.identificationModule.nctId: "NCT00707850"
protocolSection.identificationModule.officialTitle: "A Study on PEGASYS\u00ae (Peginterferon Alfa-2a (40KD)) Plus COPEGUS\u00ae (Ribavirin) in Iranian Thalassemic Patients With Chronic Hepatitis C Infection"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.